IDEXX LABORATORIES INC /DE Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IDEXX LABORATORIES INC /DE shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-06-30 was $32.91M, a 89.95% increase year-over-year.
- IDEXX LABORATORIES INC /DE shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2026-03-31 was $18.08M, a 154.10% increase year-over-year.
- IDEXX LABORATORIES INC /DE shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-09-30 was $50.97M, a 920.42% increase year-over-year.
- IDEXX LABORATORIES INC /DE shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2025-06-30 was $17.33M, a 223.28% increase year-over-year.
- IDEXX LABORATORIES INC /DE shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2025 was $93.14M, a 109.81% increase from fiscal 2024.
- IDEXX LABORATORIES INC /DE shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2024 was $44.39M, a 5.53% decline from fiscal 2023.
- IDEXX LABORATORIES INC /DE shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2023 was $46.99M, a 31.93% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2022 was $35.62M, a 23.00% decline from fiscal 2021.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2026-06-30 | $32.91M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $18.08M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $93.14M 10-K · filed 2026-02-20 | |
| 2025-09-30 | $50.97M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $17.33M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $7.11M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $44.39M 10-K · filed 2026-02-20 | |
| 2024-09-30 | $5.00M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $5.36M 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $20.78M 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $46.99M 10-K · filed 2026-02-20 | |
| 2023-09-30 | $12.62M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $10.29M 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $12.75M 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $35.62M 10-K · filed 2025-02-21 | |
| 2022-09-30 | $4.88M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $6.73M 10-Q · filed 2023-11-01 | |
| 2022-03-31 | $11.59M 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $46.26M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $9.91M 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $9.78M 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $17.43M 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $50.50M 10-K · filed 2023-02-16 | |
| 2020-09-30 | $18.72M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $10.08M 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $9.75M 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $36.02M 10-K · filed 2022-02-16 | |
| 2019-09-30 | $9.25M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $7.99M 10-Q · filed 2020-10-29 | |
| 2019-03-31 | $11.42M 10-Q · filed 2020-10-29 | |
| 2018-12-31 | $37.74M 10-K · filed 2021-02-12 | |
| 2018-09-30 | $12.81M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $7.25M 10-Q · filed 2019-10-31 | |
| 2018-03-31 | $14.09M 10-Q · filed 2019-10-31 | |
| 2017-12-31 | $39.10M 10-K · filed 2020-02-14 | |
| 2016-12-31 | $51.98M 10-K · filed 2019-02-15 | |
| 2015-12-31 | $32.76M 10-K · filed 2018-02-16 | |
| 2014-12-31 | $45.24M 10-K · filed 2017-02-17 | |
| 2013-12-31 | $51.93M 10-K · filed 2016-02-17 | |
| 2012-12-31 | $38.67M 10-K · filed 2015-02-17 | |
| 2011-12-31 | $45.87M 10-K · filed 2014-02-18 | |
| 2010-12-31 | $47.71M 10-K · filed 2013-02-19 | |
| 2009-12-31 | $22.06M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |